PURPOSE: The aim of this study was to investigate the utility of diffusion-weighted magnetic resonance (MR) imaging for prediction and early detection of response to proton beam therapy in ocular melanoma. MATERIALS AND METHODS: Ten ocular melanoma patients treated with proton beam therapy were enrolled in the study. All patients underwent conventional MR imaging and diffusion-weighted imaging (DWI) before the start of therapy, and after 1, 3 and 6 months of therapy. Tumour volumes and apparent diffusion coefficient (ADC) values of ocular lesions were measured at each examination. Tumour volumes and mean ADC measurements of the four examination series were compared; correlation of ADC values and tumour regression was investigated. RESULTS: Mean ADC value of ocular melanomas significantly increased as early as 3 months after therapy; tumour volume significantly decreased as early as 6 months after therapy. The ADC values of ocular melanomas before therapy significantly correlated with tumour regression. CONCLUSIONS: DWI may provide an early surrogate biomarker for prediction and early detection of tumour response to eye-preserving therapies in ocular melanoma.
PURPOSE: The aim of this study was to investigate the utility of diffusion-weighted magnetic resonance (MR) imaging for prediction and early detection of response to proton beam therapy in ocular melanoma. MATERIALS AND METHODS: Ten ocular melanomapatients treated with proton beam therapy were enrolled in the study. All patients underwent conventional MR imaging and diffusion-weighted imaging (DWI) before the start of therapy, and after 1, 3 and 6 months of therapy. Tumour volumes and apparent diffusion coefficient (ADC) values of ocular lesions were measured at each examination. Tumour volumes and mean ADC measurements of the four examination series were compared; correlation of ADC values and tumour regression was investigated. RESULTS: Mean ADC value of ocular melanomas significantly increased as early as 3 months after therapy; tumour volume significantly decreased as early as 6 months after therapy. The ADC values of ocular melanomas before therapy significantly correlated with tumour regression. CONCLUSIONS: DWI may provide an early surrogate biomarker for prediction and early detection of tumour response to eye-preserving therapies in ocular melanoma.
Authors: T Sugahara; Y Korogi; M Kochi; I Ikushima; Y Shigematu; T Hirai; T Okuda; L Liang; Y Ge; Y Komohara; Y Ushio; M Takahashi Journal: J Magn Reson Imaging Date: 1999-01 Impact factor: 4.813
Authors: P de Graaf; P J W Pouwels; F Rodjan; A C Moll; S M Imhof; D L Knol; E Sanchez; P van der Valk; J A Castelijns Journal: AJNR Am J Neuroradiol Date: 2011-10-27 Impact factor: 3.825
Authors: Daniel A Hamstra; Thomas L Chenevert; Bradford A Moffat; Timothy D Johnson; Charles R Meyer; Suresh K Mukherji; Douglas J Quint; Stephen S Gebarski; Xiaoying Fan; Christina I Tsien; Theodore S Lawrence; Larry Junck; Alnawaz Rehemtulla; Brian D Ross Journal: Proc Natl Acad Sci U S A Date: 2005-11-02 Impact factor: 11.205
Authors: Sungheon Kim; Laurie Loevner; Harry Quon; Eric Sherman; Gregory Weinstein; Alex Kilger; Harish Poptani Journal: Clin Cancer Res Date: 2009-02-01 Impact factor: 12.531
Authors: Patricia Rusa Pereira; Alexandre Nakao Odashiro; Li-Anne Lim; Cristina Miyamoto; Paula L Blanco; Macanori Odashiro; Shawn Maloney; Dominique F De Souza; Miguel N Burnier Journal: Clin Ophthalmol Date: 2013-08-22
Authors: Mitchell Kamrava; Ali R Sepahdari; Kevin Leu; Pin-Chieh Wang; Kristofer Roberts; D Jeffrey Demanes; Tara McCannel; Benjamin M Ellingson Journal: Neuroradiology Date: 2015-05-29 Impact factor: 2.804
Authors: Andrea Russo; Cesare Mariotti; Antonio Longo; Pietro Valerio Foti; Teresio Avitabile; Maurizio Giacinto Uva; Livio Marco Franco; Vincenza Bonfiglio; Pietro Milone; Giovanni Carlo Ettorre; Marco Ragusa; Michele Purrello; Rosario Caltabiano; Lidia Puzzo; Michele Reibaldi Journal: Radiol Med Date: 2015-02-04 Impact factor: 3.469
Authors: Pietro Valerio Foti; Antonio Longo; Michele Reibaldi; Andrea Russo; Giuseppe Privitera; Corrado Spatola; Luigi Raffaele; Vincenzo Salamone; Renato Farina; Stefano Palmucci; Andrea Musumeci; Rosario Caltabiano; Marco Ragusa; Cesare Mariotti; Teresio Avitabile; Pietro Milone; Giovanni Carlo Ettorre Journal: Radiol Med Date: 2016-10-17 Impact factor: 3.469
Authors: Pietro Valerio Foti; Mario Travali; Renato Farina; Stefano Palmucci; Corrado Spatola; Luigi Raffaele; Vincenzo Salamone; Rosario Caltabiano; Giuseppe Broggi; Lidia Puzzo; Andrea Russo; Michele Reibaldi; Antonio Longo; Paolo Vigneri; Teresio Avitabile; Giovani Carlo Ettorre; Antonio Basile Journal: Insights Imaging Date: 2021-06-03
Authors: Teresa A Ferreira; Myriam G Jaarsma-Coes; Marina Marinkovic; Berit Verbist; Robert M Verdijk; Martine J Jager; Gregorius P M Luyten; Jan-Willem M Beenakker Journal: Neuroradiology Date: 2021-10-31 Impact factor: 2.804
Authors: Maria Failla; Rosario Caltabiano; Antonio Longo; Andrea Russo; Michele Reibaldi; Teresio Avitabile; Eliana Piombino; Cristina Colarossi; Lorenzo Colarossi; Elena Tirrò; Paolo Vigneri; Pietro Valerio Foti; Giuseppe Broggi Journal: Diagnostics (Basel) Date: 2022-03-05